NewGenIvf CMO reports 39 Class B shares

NewGenIvf Group Ltd executive Fong Hei Yue Tina, who serves as Chief Marketing Officer and director, has filed a Form 3 reporting beneficial ownership of 39 Class B Ordinary Shares.

Accepted by SEC EDGAR 03/27/2026 - 06:31 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

NewGenIvf Group Ltd executive Fong Hei Yue Tina, who serves as Chief Marketing Officer and director, has filed a Form 3 reporting beneficial ownership of 39 Class B Ordinary Shares. This filing reflects an initial statement of holdings, with no buy or sell transactions indicated in the data.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Fong Hei Yue Tina

Role Chief Marketing Officer

Type	Security	Shares	Price	Value
Holding	Class B Ordinary Shares	--	--	--

Holdings: Class B Ordinary Shares — 39 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does NewGenIvf Group (NIVF) CMO report in this Form 3 filing?

The filing shows that Chief Marketing Officer and director Fong Hei Yue Tina holds beneficial ownership of 39 Class B Ordinary Shares of NewGenIvf Group Ltd. It records this position as of the reporting date without listing any purchase or sale transactions.

How many NewGenIvf (NIVF) shares does Fong Hei Yue Tina beneficially own?

According to the Form 3, Fong Hei Yue Tina beneficially owns 39 Class B Ordinary Shares of NewGenIvf Group Ltd. These shares are reported as directly held, providing a baseline view of her equity position in the company at the time of the filing.

Does the NewGenIvf (NIVF) Form 3 show any recent insider buying or selling?

The Form 3 does not show any explicit insider buying or selling transactions. It classifies the entry as a holding record, listing 39 Class B Ordinary Shares held directly, and the transaction summary reflects only a holding entry with no net buy or sell activity.

What type of shares are disclosed in NewGenIvf (NIVF) CMO’s Form 3?

The filing discloses ownership of Class B Ordinary Shares of NewGenIvf Group Ltd. It specifies that 39 such shares are held directly by Fong Hei Yue Tina, giving investors clarity on the specific class of equity reported in this initial ownership statement.

What role does the reporting person hold at NewGenIvf Group (NIVF)?

The reporting person, Fong Hei Yue Tina, is identified as both a director and an officer of NewGenIvf Group Ltd, serving as Chief Marketing Officer. The Form 3 links this leadership role with her disclosed direct ownership of 39 Class B Ordinary Shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Fong Hei Yue Tina

(Last) (First) (Middle)

C/O 1/F, PIER 2, CENTRAL

(Street)

HONG KONG

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NewGenIvf Group Ltd [ NIVF ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class B Ordinary Shares	39	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 3 is made promptly upon receipt of the access codes.

	/s/ Hei Yue Tina Fong	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)